Computer-Assisted Treatment of Urinary Tract Infection in Emergency Departments and Community Health Centers
NCT ID: NCT00731315
Last Updated: 2015-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
200 participants
INTERVENTIONAL
2008-08-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?
NCT00583648
EHR-integrated rUTI Texting Platform
NCT06035601
Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder
NCT03143920
Fecal Microbiota Transplantation for the Treatment of Recurrent Urinary Tract Infections
NCT03050515
Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment
NCT04846803
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It's important to emphasize that the computer only "fast-tracks" women who will be treated with antibiotics. All other women see the provider as usual. Also, all women who are eligible for computer treatment may opt to see a provider instead.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Group 1 - uncomplicated UTI
Would receive computer-assisted treatment for a uncomplicated UTI.
Computer-assisted treatment group
This group will receive computer-assisted expedited treatment for uncomplicated UTI or complicated cystitis based on their symptoms and past medical history reported on the computer.
Control Group 1
Qualified for expedited treatment for uncomplicated cystitis but would receive usual care in the Emergency Department of Community Health Center.
Usual care group
This group will receive usual care for an uncomplicated UTI or complicated cystitis in the Emergency Department or Community Health Center.
Treatment Group 2 - Complicated Cystitis
Would receive expedited treatment for complicated cystitis with longer antibiotic course than the simple UTI patients.
Computer-assisted treatment group
This group will receive computer-assisted expedited treatment for uncomplicated UTI or complicated cystitis based on their symptoms and past medical history reported on the computer.
Control Group 2
Qualified for expedited treatment for complicated cystitis treatment but would receive usual care in the clinic or emergency department.
Usual care group
This group will receive usual care for an uncomplicated UTI or complicated cystitis in the Emergency Department or Community Health Center.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computer-assisted treatment group
This group will receive computer-assisted expedited treatment for uncomplicated UTI or complicated cystitis based on their symptoms and past medical history reported on the computer.
Usual care group
This group will receive usual care for an uncomplicated UTI or complicated cystitis in the Emergency Department or Community Health Center.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-64 years old
Exclusion Criteria
* Male
* New flank pain
* severe vomiting
* High blood sugar or diabetes
* surgery on kidneys
* chronic kidney disease
* Previous cancer or chemotherapy
* HIV or AIDS
* pregnant or suspected pregnancy
18 Years
64 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ralph Gonzales, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francsico
John Stein, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Bradley Frazee, MD
Role: PRINCIPAL_INVESTIGATOR
Alameda County Medical Centers, Highland Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CMC Fresno Emergency Department
Fresno, California, United States
La Clinica
Oakland, California, United States
Highland Hospital Emergency Department
Oakland, California, United States
San Francisco General Hospital - Emergency Department
San Francisco, California, United States
UCSF Emergency Deparmtent
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H12132-32499-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.